BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34916248)

  • 1. Independent Prognostic Utility of
    Choi YJ; Koh Y; Lee HJ; Hwang IC; Park JB; Yoon YE; Kim HL; Kim HK; Kim YJ; Cho GY; Sohn DW; Paeng JC; Lee SP
    J Nucl Med; 2022 Jul; 63(7):1064-1069. PubMed ID: 34916248
    [No Abstract]   [Full Text] [Related]  

  • 2. Pittsburgh B Compound Positron Emission Tomography in Patients With AL Cardiac Amyloidosis.
    Lee SP; Suh HY; Park S; Oh S; Kwak SG; Kim HM; Koh Y; Park JB; Kim HK; Cho HJ; Kim YJ; Kim I; Yoon SS; Seo JW; Paeng JC; Sohn DW
    J Am Coll Cardiol; 2020 Feb; 75(4):380-390. PubMed ID: 32000949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Accuracy of [
    Rosengren S; Skibsted Clemmensen T; Tolbod L; Granstam SO; Eiskjær H; Wikström G; Vedin O; Kero T; Lubberink M; Harms HJ; Flachskampf FA; Baron T; Carlson K; Mikkelsen F; Antoni G; Frost Andersen N; Hvitfeldt Poulsen S; Sörensen J
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1337-1347. PubMed ID: 32417330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Left Ventricular
    Clerc OF; Datar Y; Cuddy SA; Bianchi G; Taylor A; Benz DC; Robertson M; Kijewski MF; Jerosch-Herold M; Kwong RY; Ruberg FL; Liao R; Di Carli MF; Falk RH; Dorbala S
    medRxiv; 2023 Sep; ():. PubMed ID: 37745589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
    Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive detection and differentiation of cardiac amyloidosis using
    Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y
    Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11C-Pittsburgh B PET imaging in cardiac amyloidosis.
    Lee SP; Lee ES; Choi H; Im HJ; Koh Y; Lee MH; Kwon JH; Paeng JC; Kim HK; Cheon GJ; Kim YJ; Kim I; Yoon SS; Seo JW; Sohn DW
    JACC Cardiovasc Imaging; 2015 Jan; 8(1):50-59. PubMed ID: 25499132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive Detection of Cardiac Amyloid With 11C-Pittsburgh Compound B PET/CT and 99mTc-PYP Scintigraphy.
    Wang X; Wang Y; Li J; Huo L; Zhang S
    Clin Nucl Med; 2021 Sep; 46(9):776-778. PubMed ID: 33883496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR).
    Pilebro B; Arvidsson S; Lindqvist P; Sundström T; Westermark P; Antoni G; Suhr O; Sörensen J
    J Nucl Cardiol; 2018 Feb; 25(1):240-248. PubMed ID: 27645889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of
    Minamimoto R; Awaya T; Iwama K; Hotta M; Nakajima K; Hirai R; Okazaki O; Hiroi Y
    J Nucl Cardiol; 2020 Feb; 27(1):202-209. PubMed ID: 29589208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of
    Wang X; Guo Y; Gao Y; Ren C; Huang Z; Liu B; Li X; Chang L; Shen K; Ding H; Zhang H; Tian Z; Hacker M; Zhang S; Wang Y; Li J; Li X; Huo L
    JACC Cardiovasc Imaging; 2022 Nov; 15(11):1960-1970. PubMed ID: 36357138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis.
    Kristen AV; Rosenberg M; Lindenmaier D; Merkle C; Steen H; Andre F; Schönland SO; Schnabel PA; Schuster T; Röcken C; Giannitsis E; Katus HA; Frey N
    Amyloid; 2014 Sep; 21(3):202-10. PubMed ID: 25007036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?
    Cuddy SAM; Bravo PE; Falk RH; El-Sady S; Kijewski MF; Park MA; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Cheng SC; Jerosch-Herold M; Kwong RY; Liao R; Dorbala S
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1325-1336. PubMed ID: 32417333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of B-Type Natriuretic Peptide for Detecting Cardiac Involvement in Immunoglobulin Amyloidosis.
    Kimishima Y; Yoshihisa A; Kiko T; Yokokawa T; Miyata-Tatsumi M; Misaka T; Oikawa M; Kobayashi A; Takeishi Y
    Int Heart J; 2019 Sep; 60(5):1106-1112. PubMed ID: 31484874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements.
    Kumar S; Dispenzieri A; Lacy MQ; Hayman SR; Buadi FK; Colby C; Laumann K; Zeldenrust SR; Leung N; Dingli D; Greipp PR; Lust JA; Russell SJ; Kyle RA; Rajkumar SV; Gertz MA
    J Clin Oncol; 2012 Mar; 30(9):989-95. PubMed ID: 22331953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of (11)C-PiB PET/MRI in the evaluation of organ involvement in primary systemic light chain amyloidosis].
    Wang YD; Yang YY; Wu YY; Sun CY
    Zhonghua Xue Ye Xue Za Zhi; 2022 Apr; 43(4):316-322. PubMed ID: 35680631
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic mortality factors in advanced light chain cardiac amyloidosis: A prospective cohort study.
    Zaroui A; Kharoubi M; Gounot R; Oghina S; Degoutte C; Bezard M; Galat A; Guendouz S; Roulin L; Audard V; Leroy V; Teiger E; Poullot E; Molinier-Frenkel V; Le Bras F; Belhadj K; Bastard JP; Fellahi S; Shourick J; Lemonier F; Damy T
    ESC Heart Fail; 2024 Jun; 11(3):1707-1719. PubMed ID: 38444090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions.
    Genovesi D; Vergaro G; Giorgetti A; Marzullo P; Scipioni M; Santarelli MF; Pucci A; Buda G; Volpi E; Emdin M
    JACC Cardiovasc Imaging; 2021 Jan; 14(1):246-255. PubMed ID: 32771577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosis.
    Datar Y; Clerc OF; Cuddy SAM; Kim S; Taylor A; Neri JC; Benz DC; Bianchi G; Yee AJ; Sanchorawala V; Ruberg FL; Landau H; Liao R; Kijewski MF; Jerosch-Herold M; Kwong RY; Di Carli MF; Falk RH; Dorbala S
    Eur Heart J Cardiovasc Imaging; 2024 Apr; 25(5):687-697. PubMed ID: 38193678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis.
    Dispenzieri A; Gertz MA; Kumar SK; Lacy MQ; Kyle RA; Saenger AK; Grogan M; Zeldenrust SR; Hayman SR; Buadi F; Greipp PR; Leung N; Russell SR; Dingli D; Lust JA; Rajkumar SV; Jaffe AS
    Heart; 2014 Mar; 100(5):383-8. PubMed ID: 24402772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.